GeoVax Applauds and Comments on Passage of $2 Trillion CARES Act Company Ready to Advance COVID-19 Vaccine Candidates to Animal Efficacy Testing, Manufacturing Scale-Up, and Human Clinical Trials ATLANTA, GA, March 30, 2020 (GLOBE NEWSWIRE) -- via...